|
|
Solid Phase Extraction
Molecularly Imprinted Polymers (SupelMIP)
|
|
|
| SupelMIP SPE is based on molecularly imprinted polymer (MIP) technology. Each SupelMIP phase offers tailor-made selectivity for the extraction of trace analytes in complex matrixes. Its superior cleanup and selectivity provide faster/simpler sample prep methods, better MS compatibility (reduced ion suppression) allowing analysts to achieve lower detection limits and improved sensitivity. |
|
MIPs are highly cross-linked polymer phases that have pre-determined selectivity for a single analyte or a group of structurally related analytes.
SupelMIP SPE phases are developed by MIP Technologies AB which is one of the leading authorities and commercial pioneers of molecularly imprinted polymers for process scale separations, analytical chromatography, and sample preparation.
The SupelMIP SPE products consist of highly cross-linked polymers that are engineered to extract a single analyte of interest or a class of structurally related analytes of interest with an extremely high degree of selectivity. This is possible because selectivity is introduced during MIP synthesis in which a template molecule, designed to mimic the analyte, guides the formation of specific cavities or imprints that are sterically and chemically complementary to the analyte(s) of interest.
|
|
· Achieve lower detection limits through superior selectivity · Save time and reduce cost via robust and rapid methodology · Stable at broad pH ranges and high temperatures · Reduce ion suppression · Stringent quality control conditions
|
|
SupelMIP SPE Binding Site
MIP binding site is both chemically and sterically complementary to the analyte(s) of interest. Multiple non-covalent interaction points (ion-exchange, reversed-phase with polymer backbone, and hydrogen bonding) between the MIP phase and analyte functional groups allow for stronger analyte retention. Improved selectivity is then introduced through the use of harsher wash conditions during sample prep methodology.
|
| |
| Superior selectivity yields lower detection limits
By careful design of the imprinting site, either by molecular modeling, experimental design, or screening methods, the binding cavities can be engineered to offer multiple interaction points with the analyte(s) of interest. This leads to a stronger interaction between the sorbent and the analyte(s). As a consequence, harsher wash conditions can be tolerated during SPE methodology resulting in cleaner extracts. Because extraction selectivity is significantly improved, lower background is observed allowing analysts to achieve lower detection limits.
Superior selectivity results in lower detection limits. Clenbuterol was extracted from 5 mL urine using SupelMIP SPE – Clenbuterol, and compared against 3 different mixed-mode SPE phases. High background and misleading responses were observed on the mixed-mode chemistries whereas the SupelMIP phases offered superior sample cleanup and lower detection limits.
|
| |
| Robust and Rapid Methodology
Sample preparation is often the rate-limiting step within the analytical process, and can often take up to 10 times as long as the analysis in itself. It is therefore critical for analysts to develop simple, robust, and rapid extraction techniques that are selective enough to achieve sensitivity, precision, and accuracy limits required of the assay. In this application example, MIP Technologies AB in collaboration with Bernhardt et al. developed an extraction method for the carcinogenic tobacco-specific NNAL or nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) from urine samples1. Total urinary NNAL is a valuable biomarker for monitoring exposure to carcinogenic TSNAs in smokers and non-smokers exposed to second-hand smoke. However, measuring the low concentrations of NNAL present in urine is challenging and typically involves multiple extraction steps that can take over one day to perform2. Using SupelMIP SPE – NNAL, even in the presence of nicotine, lower limits of quantitation were achieved, and reproducibility was increased.
| 1 |
Y. Xia et al., Anal. Chem., 77, 7639-7645 (2005) |
| 2 |
"Biomonitoring of environmental tobacco smoke (ETS)-related exposure to 4-(methylnitrosamino)-1-1(3-pyridyl)-1-butanone (NNK)" M. Merger, I. Merger-Kossien, K. Riedel and G. Scherer, Biomarkers, 2000, 5, 33-45. |
|
| |
| Stable at broad pH ranges and high temperatures
MIPs are highly cross-linked polymers that maintain stability when exposed to a broad range of organic solvents, can withstand high temperatures, and can be used over broad pH ranges, without loss of selectivity. Furthermore, they can be stored at room temperatures for prolonged periods of times. This is extremely advantageous over immunoaffinity based products.
|
| |
| SupelMIP SPE minimizes ion suppression
Mass spectrometry is a powerful quantitative tool that has been introduced into most clinical and research laboratories in recent years. When coupled to HPLC (LC-MS), the technique offers sensitivity, speed, and specificity.
Ion suppression is a common and problematic phenomenon that occurs when analyzing trace levels of analyte(s) in complex matrixes such as biological fluids. As analytical runtimes are reduced, ion suppression can often become more prevalent manifesting as poor assay accuracy and precision. Because ion suppression is often caused by the co-elution of matrix components with analyte(s) of interest, improved selectivity/sample cleanup during sample preparation is critical. Because selectivity is tailor-made during the design and production of a SupelMIP SPE phase, ion suppression is often reduced when compared to more conventional SPE phases.
|
|
|
|
| For customers who have ordered MIP[4]SPE from MIP Technologies, please refer to this product number cross-reference list. |
| |
| SupelMIP SPE Cartridges |
Sorbent mass |
Cartridge Volume |
Cartridges / box |
Part No. |
| PAHs |
50 mg |
3 mL |
50 |
52773-U |
| NSAIDs (Non-Steroidal Anti-Inflammatory Drugs) |
25 mg |
3 mL |
50 |
52769-U |
| Nitroimidazoles |
50 mg |
3 mL |
50 |
52734-U |
| Fluoroquinolones |
25 mg |
3 mL |
50 |
53269-U |
| Amphetamines |
25 mg |
3 mL |
50 |
53228-U |
| Clenbuterol |
25 mg |
10 mL |
50 |
53201-U |
| Beta-agonists (class selective) |
25 mg |
10 mL |
50 |
53202-U |
| Beta-agonists (class selective) |
25 mg |
3 mL |
50 |
53225-U |
| Beta blockers (class selective) |
25 mg |
10 mL |
50 |
53218-U |
| Beta blockers (class selective) |
25 mg |
3 mL |
50 |
53213-U |
| Full beta receptor (beta agonists and beta blockers) |
25 mg |
10 mL |
50 |
53223-U |
| Full beta receptor (beta agonists and beta blockers) |
25 mg |
3 mL |
50 |
53224-U |
| Chloramphenicol |
25 mg |
10 mL |
50 |
53210-U |
| Chloramphenicol |
25 mg |
3 mL |
50 |
53209-U |
| NNAL (4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol) |
25 mg |
10 mL |
50 |
53206-U |
| NNAL (4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol) |
25 mg |
3 mL |
50 |
53203-U |
| TSNAs (4 different Tobacco specific Nitrosamines: NNK, NNN, NAB, NAT) |
50 mg |
10 mL |
50 |
53221-U |
| TSNAs (4 different Tobacco specific Nitrosamines: NNK, NNN, NAB, NAT) |
50 mg |
3 mL |
50 |
53222-U |
| Riboflavin (vitamin B2) |
25 mg |
10 mL |
50 |
53207-U |
| Triazines (class selective) |
25 mg |
10 mL |
50 |
53208-U |
| Request a FREE SupelMIP SPE MutliPak sample |
|